Ding Wei, Luo Hui, Wang Yufei
Department of Anorectal, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, CHN.
Department of Operations Management, Luzhou Traditional Chinese Medicine Hospital, Luzhou, CHN.
Cureus. 2025 May 11;17(5):e83921. doi: 10.7759/cureus.83921. eCollection 2025 May.
Colorectal cancer is a common malignant tumor of the digestive tract, but cases concurrently complicated with lymphoma are rare. This article reports a unique case of rectal adenocarcinoma combined with diffuse large B-cell lymphoma (DLBCL) in the right colon. An 82-year-old male was admitted to the hospital due to irregular bowel movements accompanied by abdominal pain. Abdominal CT and colonoscopy suggested a malignant tumor in the rectum. During laparoscopic anterior resection of the rectum, a firm mass measuring approximately 6 cm × 5 cm was observed in the mesentery posterior to the descending and horizontal segments of the duodenum, with unclear boundaries from the ileocecal region and ascending colon. Consequently, an open right hemicolectomy was simultaneously performed. Postoperative pathology revealed well-differentiated adenocarcinoma in the rectum, while the right colon tumor and intestinal segment, combined with immunohistochemistry, were consistent with diffuse large B-cell lymphoma (not otherwise specified (NOS)) of non-germinal center origin. This case provides important clinical insights: for patients with colorectal tumors, the possibility of multiple primary cancers should be considered, especially when symptoms and imaging findings are inconsistent. Multisite biopsies and molecular pathological analysis should be employed to reduce misdiagnosis.
结直肠癌是常见的消化道恶性肿瘤,但同时合并淋巴瘤的病例罕见。本文报道了一例独特的直肠腺癌合并右半结肠弥漫性大B细胞淋巴瘤(DLBCL)的病例。一名82岁男性因排便不规律伴腹痛入院。腹部CT和结肠镜检查提示直肠有恶性肿瘤。在腹腔镜直肠前切除术过程中,在十二指肠降段和水平段后方的肠系膜中观察到一个质地硬的肿块,大小约为6 cm×5 cm,与回盲部和升结肠边界不清。因此,同时进行了开放性右半结肠切除术。术后病理显示直肠为高分化腺癌,而右半结肠肿瘤及肠段结合免疫组化结果,符合非生发中心来源的弥漫性大B细胞淋巴瘤(未另行说明(NOS))。该病例提供了重要的临床启示:对于结直肠肿瘤患者,应考虑多原发性癌的可能性,尤其是当症状和影像学表现不一致时。应采用多部位活检和分子病理分析以减少误诊。